Mesoblast (MEOBF) Property, Plant & Equipment (Net) (2014 - 2026)
Powered by 
Analysis
Mesoblast (MEOBF) Property, Plant & Equipment (Net) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn | 153.78 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - | 108.07 Mn |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn | 131.46 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 125.90 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | 11.38 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 97.61 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | 12.80 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | 325.99 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn | 105.60 Mn |
| 10 | Mesoblast | 246.02 Mn | 143.11 Mn | - | 1.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.82 Mn |
| Dec 31, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.70 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Dec 31, 2023 | 1.17 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.48 Mn |
| Dec 31, 2022 | 1.56 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 2.05 Mn |
| Mar 31, 2022 | 2.24 Mn |
| Dec 31, 2021 | 2.47 Mn |
| Sep 30, 2021 | 2.75 Mn |
| Jun 30, 2021 | 3.02 Mn |
| Mar 31, 2021 | 2.99 Mn |
| Dec 31, 2020 | 3.24 Mn |
| Sep 30, 2020 | 2.29 Mn |
| Jun 30, 2020 | 2.29 Mn |
| Mar 31, 2020 | 1.97 Mn |